Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam and MESNA in Early Acute Kidney Injury
NCT00286403Phase 3Withdrawn
- Sponsor
- Southeast Renal Research Institute
- Start
- Aug 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mesna in acute kidney injury (AKI), sponsored by Southeast Renal Research Institute. Planned start Aug 2008; status: withdrawn.
02
Drugs
mesna
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT00286403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00286403.